Active
Mainboard

Park Medi World Ltd

Park Medi World Ltd IPO Details

Listing Date

17 Dec 2025

Bid Price

₹154 - ₹162

Lot Size

92 Shares

Minimum Investment

₹14,904 / Lot

Issue Size

₹920 Cr

Key Dates to Track

    Here are the important dates you need to know in order to participate in this IPO

tick

Offer Start Date

10th Dec

tick

Offer End Date

12th Dec

tick

Allotment Date

15th Dec

tick

Refund Initiation

16th Dec

tick

Demat Transfer

16th Dec

tick

Listing Date

17th Dec

About Park Medi World Ltd IPO

Park Medi World Limited was incorporated in 2011 and runs a private hospital network in North India. The organisation has a total bed capacity of 3,000 beds as of March 31, 2025, with services offered through 14 multi-super speciality hospitals under the Park brand. The hospitals hold accreditation from the National Accreditation Board for Hospitals & Healthcare Providers (NABH), and eight facilities also hold accreditation from the National Accreditation Board for Testing and Calibration Laboratories (NABL). The network spans several locations in Haryana, Delhi, Punjab, and Rajasthan. The facilities provide a range of more than 30 speciality and super speciality medical services, including internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology.
 

As of September 30, 2025, the combined hospital infrastructure includes 870 intensive care unit beds, 67 operating theatres, and oxygen generation plants at each facility. The organisation’s presence covers multiple cities such as Ambala, Gurugram, Karnal, Panipat, Palam Vihar, Sonipat, Faridabad, Delhi, Patiala, Mohali, Jaipur, and Behror. The workforce includes 1,014 doctors and 2,142 nurses according to the available data. Bed capacity has increased from 2,550 beds in March 2023 to 3,250 beds by September 2025, and there is an indicated pipeline for future expansion across locations including Ambala, Panchkula, Rohtak, New Delhi, Gorakhpur, and Kanpur based on the disclosed plans.

Park Medi World Ltd Shareholding Pattern

  Pre-Issue Post-Issue
Promoter Group 95.55% 82.89%
Public Group 4.45% 17.11%

Park Medi World Ltd IPO Reservation

QIB Shares Offered 1,13,58,025 (20%)
NII (HNI) Shares Offered 85,18,518 (15%)
Retail Shares Offered 1,98,76,544 (35%)
Anchor Investor Shares Offered 1,70,37,036 (30%)
Total Shares Offered 5,67,90,124
Total Shares With Anchor Investor 5,67,90,124

Park Medi World Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 92 ₹14,904
Retail (Max) 13 1,196 ₹1,93,752
S HNI (Min) 14 1,288 ₹2,08,656
S HNI (Max) 67 6,164 ₹9,98,568
B HNI (MIN) 68 6,256 ₹10,13,472

Park Medi World Ltd IPO Anchor Portion Size

Bid Date December 09, 2025
Shares Offered 1,70,37,036
Anchor Investment Details 275.9999832

Park Medi World Ltd IPO registrar

KFin Techologies Ltd
Phone Number +91 40 6716 2222
Email Id einward.ris@kfintech.com
Website www.kfintech.com

Park Medi World Ltd IPO Lead Manager

1. Nuvama Wealth Management Ltd

2. CLSA India Pvt ltd

3. DAM Capital Advisors Ltd

4. Intensive Fiscal Services Pvt Ltd

Park Medi World Ltd Financial Information

March 31, 2025 March 31, 2024 March 31, 2023
Net Worth ₹1,069.58 Cr ₹882.79 Cr ₹686.56 Cr
Reserves and Surplus ₹992.7 Cr ₹805.91 Cr ₹609.68 Cr
Total Borrowing ₹622.44 Cr ₹632.65 Cr ₹557.24 Cr

Park Medi World Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid Subscription (Times)
Qualified Institutional Buyers (QIBs) 1,19,48,052 13,71,09,808 11.4755
Non Institutional Investors (NIIs) 89,61,039 13,57,18,492 15.1454
Retail Individual Investors (RIIs) 2,09,09,091 6,60,02,272 3.1566
Total 4,18,18,182 33,88,30,572 8.1

Strength of Park Medi World Ltd

  • Second largest chain of private hospitals in North India and largest private hospital chain in Haryana.
  • Delivering high-quality and affordable healthcare with a diverse specialty mix.
  • Track record of successfully acquiring and integrating hospitals.
  • Strong operational and financial performance with diversified payor mix.
  • Doctor led professional management team with industry experience.

Risks Involved

  • The company certain contingent liabilities that has been disclosed in the company financial statements. As of September 30, 2025, its contingent liabilities (excluding corporate guarantees) constituted 11.66% of the company net worth, while corporate guarantees given by the Company and Subsidiaries constituted 71.58% of our net worth. If these liabilities materialize, they may adversely affect the company results of operations, cash flows and financial condition.
  • A significant portion of our revenue from operations is derived from our hospitals located in Haryana, which comprised 74.62%, 76.92%, 83.91% and 84.98% of our revenue from operations in the six months ended September 30, 2024 and Fiscals 2024, 2023 and 2022, respectively. Any adverse developments at these hospitals or in this state could have an adverse effect on our business, results of operations and financial condition.
  • The nature of our business involves certain high costs including our cost of materials purchased, employee benefit expenses and professional and consultancy fees, and a failure to pass on such costs to patients could adversely affect our business, results of operations and financial condition.
  • We may not be able to complete or achieve the expected benefits from current or future acquisitions or successfully integrate new hospitals with our network, which could adversely affect our business and prospects.
  • We may not be successful in developing our proposed hospitals and may not achieve operating capacities that we anticipate, any of which could adversely affect our business, results of operations, financial condition and prospects.
  • Our arrangements with certain of our doctors are on a consultancy basis. If such doctors discontinue their association with us or are unable to provide their services at our hospitals, our business and results of operations may be adversely affected.
  • Certain of our Subsidiaries have experienced losses during the six months ended September 30, 2024 and the last three Fiscals. We cannot guarantee that these Subsidiaries will generate profits or avoid losses in the future.
  • We generate a significant portion of our revenues from certain key specialties such as internal medicine, neurology, urology, gastroenterology, cardiology, general surgery and orthopedics, which together contributed 92.17%, 92.87%, 92.42% and 90.39% of our revenue from operations for the six months ended September 30, 2024 and Fiscals 2024, 2023 and 2022, respectively. Any adverse developments in the demand or income from such specialties may adversely affect our business, results of operations and financial condition.
  • We are dependent on revenue generated from our in-patient department. If we are unable to maintain or increase our hospital occupancy rates at sufficient levels and generate adequate returns on our capital expenditure, our operating efficiencies and profitability may be adversely affected.
  • A significant portion of our revenue is derived from payments made by government agencies and insurance providers under various healthcare schemes. Delays in receiving payments or the rejection of claims raised by us could adversely impact our business, results of operations, financial condition and cash flows.
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Industry Outlook of Park Medi World IPO

  • The healthcare sector in India is a significant part of the overall economy and has shown steady expansion in recent years.

  • Estimates for Fiscal 2025 place the value of the domestic healthcare delivery segment at about ₹6.9 trillion to ₹7.0 trillion in total market size.

  • Industry projections suggest a compound annual growth rate (CAGR) in the range of 10% to 12% for the period up to Fiscal 2029.

  • Based on this growth range, the market size for healthcare delivery in India may reach around ₹10.2 trillion to ₹10.8 trillion by Fiscal 2029.

  • Regional data indicates that the healthcare delivery market in North India is expected to record the highest rate of expansion within the national market during this period.

  • Market share for the northern region is estimated at approximately 30% to 32% in Fiscal 2025, with an indicated range of around 30.5% to 33.5% by Fiscal 2029


Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Park Medi World IPO.

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Innovision Limited IPO
Bidding Period
10th Mar 2026 - 3rd Mar 2026
Price Range
₹521.0 - 548.0
IPO Size
₹3,22,84,00,000
Apsis Aerocom Limited IPO
Bidding Period
11th Mar 2026 - 3rd Mar 2026
Price Range
₹104.0 - 110.0
IPO Size
₹35,77,00,000
RaajMarg Infra Investment Trust IPO
Bidding Period
11th Mar 2026 - 3rd Mar 2026
Price Range
₹99.0 - 100.0
IPO Size
₹60,00,00,00,000
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanta Enterprises Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Amir Chand Jagadish Kumar Exports Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
SEDEMAC MECHATRONICS LIMITED IPO
Bidding Period
4th Mar 2026 - 3rd Mar 2026
Price Range
₹1287.0 - 1352.0
IPO Size
₹10,87,00,00,000
ACETECH ECOMMERCE LIMITED IPO
Bidding Period
27th Feb 2026 - 3rd Mar 2026
Price Range
₹106.0 - 112.0
IPO Size
₹49,00,00,000
STRIDERS IMPEX LIMITED IPO
Bidding Period
26th Feb 2026 - 3rd Mar 2026
Price Range
₹71.0 - 72.0
IPO Size
₹36,00,00,000
YAAP DIGITAL LIMITED IPO
Bidding Period
25th Feb 2026 - 2nd Feb 2026
Price Range
₹138.0 - 145.0
IPO Size
₹80,11,00,000
OMNITECH ENGINEERING LIMITED IPO
Bidding Period
25th Feb 2026 - 2nd Feb 2026
Price Range
₹216.0 - 227.0
IPO Size
₹5,83,00,00,000
PNGS REVA DIAMOND JEWELLERY LIMITED IPO
Bidding Period
24th Feb 2026 - 2nd Feb 2026
Price Range
₹367.0 - 386.0
IPO Size
₹3,80,00,00,000
SHREE RAM TWISTEX LIMITED IPO
Bidding Period
23rd Feb 2026 - 2nd Feb 2026
Price Range
₹95.0 - 104.0
IPO Size
₹1,10,24,00,000
KIAASA RETAIL LIMITED IPO
Bidding Period
23rd Feb 2026 - 2nd Feb 2026
Price Range
₹121.0 - 127.0
IPO Size
₹70,00,00,000
MOBILISE APP LAB LIMITED IPO
Bidding Period
23rd Feb 2026 - 2nd Feb 2026
Price Range
₹75.0 - 80.0
IPO Size
₹20,00,00,000
ACCORD TRANSFORMER AND SWITCHGEAR LIMITED IPO
Bidding Period
23rd Feb 2026 - 2nd Feb 2026
Price Range
₹43.0 - 46.0
IPO Size
₹26,00,00,000
CLEAN MAX ENVIRO ENERGY SOLUTIONS LIMITED IPO
Bidding Period
23rd Feb 2026 - 2nd Feb 2026
Price Range
₹1000.0 - 1053.0
IPO Size
₹31,00,00,00,000
GAUDIUM IVF AND WOMEN HEALTH LIMITED IPO
Bidding Period
20th Feb 2026 - 2nd Feb 2026
Price Range
₹75.0 - 79.0
IPO Size
₹1,65,00,00,000
MANILAM INDUSTRIES INDIA LIMITED IPO
Bidding Period
20th Feb 2026 - 2nd Feb 2026
Price Range
₹65.0 - 69.0
IPO Size
₹40,00,00,000
FRACTAL INDUSTRIES LIMITED IPO
Bidding Period
16th Feb 2026 - 2nd Feb 2026
Price Range
₹205.0 - 216.0
IPO Size
₹49,00,00,000
MARUSHIKA TECHNOLOGY LIMITED IPO
Bidding Period
12th Feb 2026 - 2nd Feb 2026
Price Range
₹111.0 - 117.0
IPO Size
₹27,00,00,000
FRACTAL ANALYTICS LIMITED IPO
Bidding Period
9th Feb 2026 - 2nd Feb 2026
Price Range
₹857.0 - 900.0
IPO Size
₹28,34,00,00,000
AYE FINANCE LIMITED IPO
Bidding Period
9th Feb 2026 - 2nd Feb 2026
Price Range
₹122.0 - 129.0
IPO Size
₹10,10,00,00,000
BIOPOL CHEMICALS LIMITED IPO
Bidding Period
6th Feb 2026 - 2nd Feb 2026
Price Range
₹102.0 - 108.0
IPO Size
₹31,00,00,000
PAN HR SOLUTION LIMITED IPO
Bidding Period
6th Feb 2026 - 2nd Feb 2026
Price Range
₹74.0 - 78.0
IPO Size
₹17,00,00,000
NFP SAMPOORNA FOODS LIMITED IPO
Bidding Period
4th Feb 2026 - 2nd Feb 2026
Price Range
₹52.0 - 55.0
IPO Size
₹25,00,00,000
  • All
  • MainBoard
  • SME
PNGS REVA DIAMOND JEWELLERY LIMITED IPO
Issue Prize
386.00
Listing Day Close
413.95(7.25%)
SHREE RAM TWISTEX LIMITED IPO
Issue Prize
104.00
Listing Day Close
73.45(-29.81%)
KIAASA RETAIL LIMITED IPO
Issue Prize
127.00
Listing Day Close
116.85(-7.87%)
MOBILISE APP LAB LIMITED IPO
Issue Prize
80.00
Listing Day Close
67.30(-16.25%)
ACCORD TRANSFORMER AND SWITCHGEAR LIMITED IPO
Issue Prize
46.00
Listing Day Close
52.50(15.22%)
CLEAN MAX ENVIRO ENERGY SOLUTIONS LIMITED IPO
Issue Prize
1053.00
Listing Day Close
867.90(-17.57%)
GAUDIUM IVF AND WOMEN HEALTH LIMITED IPO
Issue Prize
79.00
Listing Day Close
80.48(1.27%)
MANILAM INDUSTRIES INDIA LIMITED IPO
Issue Prize
69.00
Listing Day Close
52.45(-24.64%)
FRACTAL INDUSTRIES LIMITED IPO
Issue Prize
216.00
Listing Day Close
217.55(0.93%)
MARUSHIKA TECHNOLOGY LIMITED IPO
Issue Prize
117.00
Listing Day Close
114.00(-2.56%)
FRACTAL ANALYTICS LIMITED IPO
Issue Prize
900.00
Listing Day Close
847.40(-5.89%)
AYE FINANCE LIMITED IPO
Issue Prize
129.00
Listing Day Close
128.90(0.00%)
BIOPOL CHEMICALS LIMITED IPO
Issue Prize
108.00
Listing Day Close
105.50(-1.85%)
PAN HR SOLUTION LIMITED IPO
Issue Prize
78.00
Listing Day Close
78.01(0.00%)
BRANDMAN RETAIL LIMITED IPO
Issue Prize
176.00
Listing Day Close
192.15(9.09%)
GROVER JEWELLS LIMITED IPO
Issue Prize
88.00
Listing Day Close
100.80(14.77%)
C K K RETAIL MART LIMITED IPO
Issue Prize
163.00
Listing Day Close
171.15(4.91%)
ACCRETION NUTRAVEDA LIMITED IPO
Issue Prize
129.00
Listing Day Close
191.20(48.06%)
MSAFE EQUIPMENTS LIMITED IPO
Issue Prize
123.00
Listing Day Close
150.30(21.95%)
KANISHK ALUMINIUM INDIA LIMITED IPO
Issue Prize
73.00
Listing Day Close
55.48(-24.66%)

Frequently Asked Questions

What is Park Medi World Ltd IPO?

Answer Field

Park Medi World Ltd IPO is a Mainboard IPO of 5,67,90,124 equity shares of a face value of ₹2 aggregating up to ₹920 Crores. The issue is priced at ₹154 to ₹162 per share. The minimum order quantity is 92 Shares. The IPO opens on December 10, 2025, and closes on December 12, 2025. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

When Park Medi World Ltd IPO will open?

Answer Field

The Park Medi World Ltd IPO opens on December 10, 2025 and closes on December 12, 2025.

What is the lot size of Park Medi World Ltd?

Answer Field

Park Medi World Ltd lot size is 92 shares, and the minimum amount required is ₹14,904.

How to apply for Park Medi World Ltd IPO?

Answer Field

You can apply in Park Medi World Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Park Medi World Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Park Medi World Ltd IPO will be done on December 15, 2025, and the allotted shares will be credited to your demat account by December 16, 2025.

When is Park Medi World Ltd IPO listing date?

Answer Field

The Park Medi World Ltd listing date is December 17, 2025.

Who is the registrar of Park Medi World Ltd IPO?

Answer Field

The registrar of Park Medi World Ltd IPO is KFin Techologies Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Nuvama Wealth Management Ltd,CLSA India Pvt ltd,DAM Capital Advisors Ltd,Intensive Fiscal Services Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Park Medi World Ltd IPO?

Answer Field

The fresh issue size is ₹770 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Park Medi World Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 92 shares and ₹14,904 amount.

How can I approve the UPI mandate request for Park Medi World Ltd IPO?

Answer Field

To apply for Park Medi World Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Park Medi World Ltd?

Answer Field

The price of each Park Medi World Ltd share will be ranging in between ₹154 to ₹162 per share.

What is the cut-off time for the UPI mandate for Park Medi World Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, December 12, 2025.

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|